BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23751876)

  • 21. PDE5 expression in human thyroid tumors and effects of PDE5 inhibitors on growth and migration of cancer cells.
    Sponziello M; Verrienti A; Rosignolo F; De Rose RF; Pecce V; Maggisano V; Durante C; Bulotta S; Damante G; Giacomelli L; Di Gioia CR; Filetti S; Russo D; Celano M
    Endocrine; 2015 Nov; 50(2):434-41. PubMed ID: 25837309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of genes involved in miRNA biogenesis in medullary thyroid carcinomas with RET mutation.
    Puppin C; Durante C; Sponziello M; Verrienti A; Pecce V; Lavarone E; Baldan F; Campese AF; Boichard A; Lacroix L; Russo D; Filetti S; Damante G
    Endocrine; 2014 Nov; 47(2):528-36. PubMed ID: 24569963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential miRNA expression defines migration and reduced apoptosis in follicular thyroid carcinomas.
    Wojtas B; Ferraz C; Stokowy T; Hauptmann S; Lange D; Dralle H; Musholt T; Jarzab B; Paschke R; Eszlinger M
    Mol Cell Endocrinol; 2014 May; 388(1-2):1-9. PubMed ID: 24631480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How to define follicular thyroid carcinoma?
    Schmid KW; Farid NR
    Virchows Arch; 2006 Apr; 448(4):385-93. PubMed ID: 16506015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular differences between human thyroid follicular adenoma and carcinoma revealed by analysis of a murine model of thyroid cancer.
    Sponziello M; Lavarone E; Pegolo E; Di Loreto C; Puppin C; Russo MA; Bruno R; Filetti S; Durante C; Russo D; Di Cristofano A; Damante G
    Endocrinology; 2013 Sep; 154(9):3043-53. PubMed ID: 23751876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Follicular thyroid cancers demonstrate dual activation of PKA and mTOR as modeled by thyroid-specific deletion of Prkar1a and Pten in mice.
    Pringle DR; Vasko VV; Yu L; Manchanda PK; Lee AA; Zhang X; Kirschner JM; Parlow AF; Saji M; Jarjoura D; Ringel MD; La Perle KM; Kirschner LS
    J Clin Endocrinol Metab; 2014 May; 99(5):E804-12. PubMed ID: 24512487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of estrogen receptor Beta expression in follicular thyroid carcinoma predicts poor outcome.
    Heikkilä A; Hagström J; Mäenpää H; Louhimo J; Siironen P; Heiskanen I; Haglund C; Arola J
    Thyroid; 2013 Apr; 23(4):456-65. PubMed ID: 23106428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA-G is differentially expressed in thyroid tissues.
    de Figueiredo Feitosa NL; Crispim JC; Zanetti BR; Magalhães PK; Soares CP; Soares EG; Neder L; Donadi EA; Maciel LM
    Thyroid; 2014 Mar; 24(3):585-92. PubMed ID: 24089994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and clinicopathological role of miR146a in thyroid follicular carcinoma.
    Pignatti E; Vighi E; Magnani E; Kara E; Roncati L; Maiorana A; Santi D; Madeo B; Cioni K; Carani C; Rochira V; Simoni M; Brigante G
    Endocrine; 2019 Jun; 64(3):575-583. PubMed ID: 30701447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of RET in follicular cell-derived tumors of the thyroid gland: prevalence and implication of morphological type.
    Inaba M; Umemura S; Satoh H; Abe Y; Kurokawa K; Sakai H; Osamura RY
    Pathol Int; 2003 Mar; 53(3):146-53. PubMed ID: 12608895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology.
    Alexander EK; Kennedy GC; Baloch ZW; Cibas ES; Chudova D; Diggans J; Friedman L; Kloos RT; LiVolsi VA; Mandel SJ; Raab SS; Rosai J; Steward DL; Walsh PS; Wilde JI; Zeiger MA; Lanman RB; Haugen BR
    N Engl J Med; 2012 Aug; 367(8):705-15. PubMed ID: 22731672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mouse models of follicular and papillary thyroid cancer progression.
    Russo MA; Antico Arciuch VG; Di Cristofano A
    Front Endocrinol (Lausanne); 2011; 2():119. PubMed ID: 22654848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples.
    Nikiforov YE; Ohori NP; Hodak SP; Carty SE; LeBeau SO; Ferris RL; Yip L; Seethala RR; Tublin ME; Stang MT; Coyne C; Johnson JT; Stewart AF; Nikiforova MN
    J Clin Endocrinol Metab; 2011 Nov; 96(11):3390-7. PubMed ID: 21880806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular genetics and diagnosis of thyroid cancer.
    Nikiforov YE; Nikiforova MN
    Nat Rev Endocrinol; 2011 Aug; 7(10):569-80. PubMed ID: 21878896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Global quantification of mammalian gene expression control.
    Schwanhäusser B; Busse D; Li N; Dittmar G; Schuchhardt J; Wolf J; Chen W; Selbach M
    Nature; 2011 May; 473(7347):337-42. PubMed ID: 21593866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A large multicenter correlation study of thyroid nodule cytopathology and histopathology.
    Wang CC; Friedman L; Kennedy GC; Wang H; Kebebew E; Steward DL; Zeiger MA; Westra WH; Wang Y; Khanafshar E; Fellegara G; Rosai J; Livolsi V; Lanman RB
    Thyroid; 2011 Mar; 21(3):243-51. PubMed ID: 21190442
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.